Abstract: genetic programming (GP) is a widely recognized and powerful approach for symbolic regression (SR) problems. However, existing GP methods rely on a single form to solve the problem, which ...

If brain tumors were sharks, the glioblastoma multiforme, or GBM, would be the great white. More than any other brain cancer, GBM inspires fear because of its almost unstoppable aggression. In fact, ...

Abstract: Feature selection in machine learning as a key data processing technique has two conflicting goals: 1) minimizing the classification error rate and 2 ...

REDWOOD CITY, Calif., Oct. 7, 2025 /PRNewswire/ -- Precision NeuroMed (PNM), a clinical-stage biotechnology company pioneering advanced drug delivery technologies for central nervous system (CNS) ...

Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to advance innovative Theranostic radiopharmaceuticals to address unmet needs in oncology HOUSTON and MARSEILLE ...

BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...

Glioblastoma multiforme (GBM) is an exceedingly aggressive primary brain neoplasm characterized by a dismal prognosis owing to its invasiveness, heterogeneity, and immunity to conventional therapies.

State Key Laboratory of Precision Electronic Manufacturing Technology and Equipment, Guangdong University of Technology, Guangzhou, Guangdong 510006, China School of Electromechanical Engineering, ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...